MIMEDX GROUP INC
For the period ended Dec 31, 2024. Filed Feb 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 26, 2025
MDXG$3.37+1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations – For the years ended
(in thousands, except share and per share data)
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Net sales | $348,879 | $321,477 | $267,841 |
| Cost of sales | 60,073 | 54,634 | 48,316 |
| Gross profit | 288,806 | 266,843 | 219,525 |
| Operating expenses: | |||
| Selling, general and administrative | 225,087 | 211,124 | 208,673 |
| Research and development | 12,341 | 12,665 | 12,701 |
| Investigation, restatement and related | (8,698) | 5,176 | 12,177 |
| Amortization of intangible assets | 765 | 762 | 701 |
| Impairment of intangible assets | 446 | — | — |
| Operating income (loss) | 58,865 | 37,116 | (14,727) |
| Other expense, net | |||
| Interest expense, net | (1,006) | (6,457) | (5,016) |
| Other expense, net | (565) | (26) | (4) |
| Income (loss) from continuing operations before income tax provision | 57,294 | 30,633 | (19,747) |
| Income tax provision (expense) benefit from continuing operations | (15,296) | 36,806 | (206) |
| Net income (loss) from continuing operations | 41,998 | 67,439 | (19,953) |
| Income (loss) from discontinued operations, net of tax | 421 | (9,211) | (10,244) |
| Net income (loss) | $42,419 | $58,228 | $(30,197) |
| Net income (loss) available to common stockholders from continuing operations | $41,998 | $55,796 | $(26,533) |
| Basic net income (loss) per common share: | |||
| Continuing operations | $0.29 | $0.48 | $(0.24) |
| Discontinued operations | 0.00 | (0.08) | (0.09) |
| Basic net income (loss) per common share: | $0.29 | $0.40 | $(0.33) |
| Diluted net income (loss) per common share: | |||
| Continuing operations | $0.28 | $0.43 | $(0.24) |
| Discontinued operations | 0.00 | (0.06) | (0.09) |
| Diluted net income (loss) per common share: | $0.28 | $0.37 | $(0.33) |
| Weighted average common shares outstanding - basic | 146,979,354 | 116,495,810 | 112,909,266 |
| Weighted average common shares outstanding - diluted | 149,049,197 | 145,962,462 | 112,909,266 |
F- 5
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.